Latest Takeover News

The Takeovers Panel has issued interim orders extending the deadline for Mayne Pharma's takeover scheme with Cosette Pharmaceuticals, preventing termination without consent and maintaining the status quo.

The Takeovers Panel has intervened in the Mayne Pharma and Cosette Pharmaceuticals scheme, issuing interim orders that extend the deal deadline and restrict termination rights to maintain the status quo.

Robex Resources has filed a management information circular ahead of a December 15 shareholder vote on a proposed acquisition by Predictive Discovery. The deal promises to create a West African gold mining powerhouse.

Capricorn Metals Ltd has officially completed its acquisition of Warriedar Resources Limited through a court-approved scheme of arrangement, marking a significant consolidation in the gold mining sector.

Suzerain Investment Holdings Ltd has initiated an off-market takeover offer for all remaining shares in Entertainment Rewards Ltd at a significant premium, aiming to consolidate full ownership and potentially delist the company from the ASX.

The Supreme Court of Western Australia has approved the share and option schemes for Capricorn Metals’ acquisition of Warriedar Resources, setting the stage for a significant consolidation in the gold exploration sector.

The Australian Competition and Consumer Commission has given the green light to Southern Cross Media’s proposed acquisition of Seven West Media, marking a significant regulatory milestone in the evolving Australian media landscape.

AUB Group delivered a robust FY25 with a 17.1% rise in underlying net profit and a 15% dividend increase, while navigating a $45 per share acquisition proposal from an EQT-CVC consortium.

TT Investments has confirmed that its all-cash takeover offer for 360 Capital Group will close on 13 November 2025 without extension, marking a decisive moment for the ASX-listed investment manager.

Rover Group has completed its acquisition of Mad Paws, marking the pet services marketplace’s exit from the ASX with shareholders paid $0.14 per share.

Mayne Pharma has received notice of Cosette Pharmaceuticals' intention to appeal a court ruling in their acquisition dispute, potentially delaying the proposed takeover. The legal saga continues as key approvals and hearings loom.

AUB Group has approved EQT's partnership with CVC Asia Pacific to jointly pursue a $45 per share acquisition, extending exclusivity to December 4 as due diligence continues.